AnnumeVitality Lab

Annume Vitality Lab

Explore the research.

A guide to selected compounds, the questions being studied and where the evidence stands.

Research references, with context.

This catalog is a starting point for learning about selected compounds and medicines. Entries are educational references, not products available from Annume.

FDA-approved medicines exist

Semaglutide

Semaglutide is the active ingredient in approved prescription medicines. Wegovy has approved weight-management uses; the product, formulation and indication matter. Approval of a medicine does not extend to every vial sold under the ingredient name.

FDA-approved medicines exist

Tirzepatide

Tirzepatide is the active ingredient in Zepbound and Mounjaro. Zepbound has approved weight-management uses. Prescription medicines have defined indications, risks and labeling; a research catalog cannot determine whether a medicine is appropriate for you.

Investigational · Published phase 3 research

Retatrutide

Retatrutide activates GIP, GLP-1 and glucagon receptors. Published phase 3 trials report weight-loss results in defined patient groups. It remains unapproved, and FDA states that it cannot be compounded under federal law.

Investigational · Body-composition research

Bimagrumab

Bimagrumab is an antibody studied for its effects on fat and lean mass, including in combination with semaglutide. The BELIEVE study examines a different approach from weight loss alone. A body-composition result does not establish improved strength or longer life.

Investigational · Muscle-preservation research

Trevogrumab

Trevogrumab is an antibody that blocks myostatin. The COURAGE program studies it alongside semaglutide. Lean mass, muscle volume and physical function are different outcomes and should be read separately.

Look beyond the compound name.

What was tested, in whom, against which comparison, and for how long?

A trial finding does not verify the identity, quality or safety of a product sold elsewhere. Research-use labeling does not establish suitability for human use. For current treatment options, speak with a licensed clinician.

Read status carefully

Status here refers to the United States and was checked November 7, 2026. A medicine's approval concerns specified products and uses. Compounded drugs are not FDA-approved, and compounding is subject to separate legal requirements.